Final results of a GRAN-T-MTC phase I clinical trial using a novel CCK2 receptor-localising radiolabelled peptide probe for personalized diagnosis and therapy of patients withmetastatic medullary thyroid cancer

L. Lezaic, P. Kolenc, K. Zaletel, P. Erba, C. Decristoforo, R. Mikolajczak, P. Garnuszek, I. Virgolini, C. Rangger,G. Di Santo, H. Maecke, T. Maina, B. A. Nock, M. Trofimiuk-Muldner, E. Przybylik-Mazurek,M. de Jong, A. C. Froberg, M. Konijnenberg,K. Skorkiewicz, B. Solnica, D. Fedak, P. Gaweda, A. Hubalewska-Dydejczyk

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2022）

引用 1|浏览0

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要